You might notice some minor bruising at the IV site, but that's typical with any IV procedure and fades within a few days
This is based on how well the patient responds and the severity of their deficiency
NPI-001 has the potential to treat a broad set of diseases and conditions associated with oxidative stress and reduced glutathione levels such as slowing or stopping disease progression in retinitis pigmentosa patients with functional cones, regardless of their disease-causing genetic mutation

The armenian hamster FITC anti-CD11c antibody (117306, N418, B356966), armenian hamster PE anti-CD80 antibody (104707, 16-10A1, B340153), rat APC anti-CD86 antibody (105011, GL-1, B323580), rat BV421 anti-CD45 antibody (103134, 30-F11, B370002), rat APC anti-CD3 antibody (100236, 17A2, B375907), rat FITC anti-CD4 antibody (100406, GK1.5, B374032), rat PerCP anti-CD8 alpha antibody (100732, 53-6.7, B386876), rat PE anti-CD62L antibody (104407, MEL-14, B242685), rat FITC anti-CD44 antibody (103006, IM7, B323775), Zombie Yellow (423103, B330652), rat BV510 anti-CD45 antibody (103138, 30-F11, B402130), rat APC/Cyanine7 anti-CD11b antibody (101225, M1/70, B397990), rat BV421 anti-F4/80 antibody (123137, BM8, B416422), rat PE anti-Ly-6G antibody (127607, 1A8, B397726), armenian hamster FITC anti-CD80 antibody (104705, 16-10A1, B354433), rat PE/Cyanine7 anti-CD206 antibody (141719, C068C2, B399589), and rat anti-CD16/32 antibody (101302, 93, B269215) were purchased from Biolegend Company (Beijing, China)

Neoplasia 83 ShibataT.KokubuA.GotohM.OjimaH.OhtaT.YamamotoM.et al (2008a)
- The skin is protected from the sun and environmental damages